000			01464 a2200397 4500
005			20250513223413.0
264		0	_c20001222
008			200012s 0 0 eng d
022			_a0165-5728
024	7		_a10.1016/s0165-5728(00)00395-7 _2doi
040			_aNLM _beng _cNLM
100	1		_aIm, S H
245	0	0	_aMechanism of nasal tolerance induced by a recombinant fragment of acetylcholine receptor for treatment of experimental myasthenia gravis. _h[electronic resource]
260			_bJournal of neuroimmunology _cNov 2000
300			_a161-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Intranasal
650	0	4	_aAnimals
650	0	4	_aAntigen Presentation _ximmunology
650	0	4	_aFemale
650	0	4	_aImmune Tolerance _xdrug effects
650	0	4	_aImmunotherapy
650	0	4	_aMyasthenia Gravis, Autoimmune, Experimental _ximmunology
650	0	4	_aPeptide Fragments _ximmunology
650	0	4	_aRats
650	0	4	_aRats, Inbred Lew
650	0	4	_aReceptors, Cholinergic _ximmunology
650	0	4	_aRecombinant Proteins _ximmunology
650	0	4	_aTh1 Cells _ximmunology
650	0	4	_aTh2 Cells _ximmunology
700	1		_aBarchan, D
700	1		_aFuchs, S
700	1		_aSouroujon, M C
773	0		_tJournal of neuroimmunology _gvol. 111 _gno. 1-2 _gp. 161-8
856	4	0	_uhttps://doi.org/10.1016/s0165-5728(00)00395-7 _zAvailable from publisher's website
999			_c11006347 _d11006347